CAH EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
CAH's ev/ebitda is higher than 82% of the last 10 years.
EV/EBITDA History
CAH EV/EBITDA by year
Yearly range of CAH’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 5.9 to 280.7, averaging 22.6.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 15.9 | 17.7 | 20.2 | 18.3 |
| 2025 | 11.4 | 13.9 | 17.0 | 17.0 |
| 2024 | 11.2 | 13.9 | 17.5 | 12.4 |
| 2023 | 15.6 | 21.9 | 35.6 | 20.7 |
| 2022 | 20.1 | 119.5 | 280.7 | 267.2 |
| 2021 | 7.2 | 10.4 | 20.4 | 20.4 |
| 2020 | 8.6 | 9.5 | 10.5 | 8.9 |
| 2019 | 5.9 | 10.2 | 13.7 | 6.5 |
| 2018 | 8.7 | 13.8 | 21.5 | 11.6 |
| 2017 | 8.4 | 9.7 | 11.7 | 10.8 |
| 2016 | 8.0 | 8.9 | 9.6 | 8.7 |
Get notified when CAH EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is CAH EV/EBITDA High or Low Right Now?
Cardinal Health, Inc.'s EV/EBITDA is currently 18.3, which is historically pricey relative to its 10-year historical range. The 10-year median EV/EBITDA for CAH is approximately 13.2. See all CAH valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.